Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU7-111P (RNA, U7 small nuclear 111 pseudogene)** is annotated as a small nuclear RNA (snRNA) pseudogene in the human genome[1]. It belongs to the class of pseudogenes, which are genomic DNA sequences similar to normal genes but are typically non-functional due to mutations or truncations that prevent their expression as functional RNAs or proteins[2]. Normally, the U7 small nuclear RNA is involved in the processing of histone pre-mRNAs; however, as a pseudogene, RNU7-111P is not known to produce a functional RNA and has no demonstrated biological activity[1][2]. There are no reported disease associations, functional roles, drug interactions, or utility as a biomarker for this pseudogene. Pseudogenes can sometimes act as regulators or decoys for RNAs or microRNAs, but there is no evidence in the literature of such a function for RNU7-111P[2]. *Note: This entry is likely not a therapeutically relevant target, nor a receptor or enzyme, but a non-functional genomic sequence derived from the U7 small nuclear RNA gene.* **Reason for is_incorrect:** - "RNA, U7 small nuclear 111 pseudogene" (RNU7-111P) is a pseudogene, not an active molecular target such as a receptor, enzyme, transporter, etc. - There is no evidence it encodes a functional product or participates in biological pathways as a drug target[1][2]. - It is included in genomic databases mainly to annotate pseudogenes, not as a candidate therapeutic or biomarker. **Summary:** RNU7-111P is a human pseudogene derived from the U7 small nuclear RNA gene, not known to produce functional RNA, and is not a therapeutic target[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 111 pseudogene (RNU7-111P).